KemPharma Balance Sheet - Annual (NASDAQ:KMPH)

Add to My Stocks
$4.95 $0.03 (0.6%) KMPH stock closing price Sep 19, 2018 (Closing)

The financial analysis of a company involves interpreting the income statement, balance sheet and cash flow statements of the company to draw insights like we've done in our KemPharma stock analysis. All three financial statements should be used to measure the financial performance of the company, and should form a part of the KemPharma stock analysis. Annual results are typically accompanied with the company releasing financial statements. KemPharma balance sheet indicates an asset turnover ratio of and debt to equity ratio of . Also check KemPharma revenue and KemPharma operating cash flow for the same period.

View latest 10 year balance sheet data to check KemPharma financial performance.
show more
Fiscal year is Jan - Dec20172016201520142013
Cash11.97M17.86M32.31M10.25M1.96M
Marketable Securities31.35M51M19M--
Receivables2M5M---
Inventory-----
Raw Materials-----
Work In Progress-----
Finished Goods-----
Notes Receivable-----
Other Current Assets1.66M-2.75M--
Total Current Assets
46.99M74.35M54.07M10.27M2.03M
Property Plant & Equipment2.93M2.57M---
Accumulated Depreciation-----
Net Property Plant & Equipment
2M1.97M---
Investment & Advances3.25M8.2M---
Other Non-Current Assets-----
Deferred Charges--1.13M1.46M-
Intangibles-----
Deposits & Other Assets---1.61M-
Total Assets
52.45M84.88M55.72M13.71M2.42M
Notes Payable3.33M-1.36M-3.84M
Accounts Payable7.87M6.44M4.9M3.9M1.36M
Current Portion Long-Term Debt--2.04M--
Current Portion Capital Leases-----
Accrued Expenses-----
Income Taxes Payable-----
Other Current Liabilities-----
Total Current Liabilities
11.5M6.64M8.34M3.93M5.24M
Mortgages-----
Deferred Taxes/Income-----
Convertible Debt89.39M91.17M7.86M7.23M-
Long-Term Debt--11.79M10.85M-
Non-Current Capital Leases-----
Other Long-Term Liabilities8.5M5.77M37.83M15.96M2.81M
Total Liabilities
109.97M103.58M65.84M38.01M8.14M
Minority Interest-----
Preferred Stock---24.2M18.54M
Common Stock Net----1.43M
Capital Surplus107.2M102.64M94.7M1.65M-
Retained Earnings-164.72M-121.34M-104.82M-50.16M-25.7M
Treasury Stock-----
Other Liabilities-----
Shareholders Equity-57.51M-18.69M-10.12M-24.3M-24.26M
Total Liabilities & Shareholders Equity52.45M84.88M55.72M13.71M2.42M
All figures in USD. M: Millions of USD, B: Billions of USD.

The latest KemPharma stock price, and KemPharma historical stock prices show the stock price movement over time, and the KemPharma PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:

  • Assets: KMPH total assets, which was at $52.45M for 2017 is a balance sheet item representing value of what KemPharma owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of KemPharma for the year 2017 total to $109.97M. Liabilities for a company like KemPharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

KemPharma Balance Sheet - Key Ratios